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Abstract
Methamphetamine (meth) is a highly addictive and widely abused psychostimulant. Repeated use of meth can quickly lead
to dependence, and may be accompanied by a variety of persistent psychiatric symptoms and cognitive impairments. The
neuroadaptations underlying motivational and cognitive deficits produced by chronic meth intake remain poorly
understood. Altered glutamate neurotransmission within the prefrontal cortex (PFC) and striatum has been linked to both
persistent drug-seeking and cognitive dysfunction. Therefore, the current study investigated changes in presynaptic mGluR
receptors within corticostriatal circuitry after extended meth self-administration. Rats self-administered meth (or received
yoked-saline) in 1 hr/day sessions for 7 days (short-access) followed by 14 days of 6 hrs/day (long-access). Rats displayed a
progressive escalation of daily meth intake up to 6 mg/kg per day. After cessation of meth self-administration, rats
underwent daily extinction or abstinence without extinction training for 14 days before being euthanized. Synaptosomes
from the medial PFC, nucleus accumbens (NAc), and the dorsal striatum (dSTR) were isolated and labeled with membrane-
impermeable biotin in order to measure surface mGluR2/3 and mGluR7 receptors. Extended access to meth self-
administration followed by abstinence decreased surface and total levels of mGluR2/3 receptors in the NAc and dSTR, while
in the PFC, only a loss of surface mGluR2/3 and mGluR7 receptors was detected. Daily extinction trials reversed the
downregulation of mGluR2/3 receptors in the NAc and dSTR and mGluR7 in the PFC, but downregulation of surface
mGluR2/3 receptors in the PFC was present regardless of post-meth experience. Thus, extinction learning can selectively
restore some populations of downregulated mGluRs after prolonged exposure to meth. The present findings could have
implications for our understanding of the persistence (or recovery) of meth-induced motivational and cognitive deficits.
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Introduction
Methamphetamine (meth) is a widely abused and highly
addictive psychostimulant. While acute meth produces short-term
‘positive’ subjective effects and increased psychomotor/cognitive
performance [1], continued abuse often leads to compulsive drug
taking, addiction, and long-term deleterious health consequences.
In addition to meth-induced peripheral pathologies (e.g., weight
loss, cardiovascular toxicity, and severe tooth decay), chronic meth
use can result in a variety of psychiatric symptoms and cognitive
impairments. Psychosis, attention and memory deficits, impulsiv-
ity, and increased anxiety and aggression have been documented
in active and abstinent meth addicts [2,3,4,5,6]. Clinical studies
consistently demonstrate that chronic meth users have high rates
of relapse that are equal to, if not higher than, drugs such as
cocaine and heroin [7]. Despite the fact that meth represents a
serious health concern, cognitive behavioral therapy constitutes
the only treatment option [8,9] as no approved pharmacotherapies
exist for the treatment of meth addiction and its neuropsycholog-
ical consequences [10].
Our limited understanding of chronic meth-induced neuroa-
daptations in humans or experimental animals has impeded the
development of successful meth addiction treatment. Rodent
models of extended daily access to meth self-administration are
highly suitable for identifying such plasticities, as they possess good
face validity for meth addiction in humans. As such, rats with
extended daily access to intravenous meth typically display
escalation of meth-intake [11,12,13] and enhanced drug-seeking
[12,13] when compared to more limited-access conditions. In
addition, extended meth access in rats results in lasting cognitive
impairments, specifically in attention and memory domains
[12,14], similar to those observed in a significant portion of meth
addicts [2].
Meth rapidly increases extracellular levels of monoamines,
enhancing dopamine, norepinephrine, and serotonin release
[4,15]. In addition to monoamines, acute meth exposure increases
extracellular glutamate in several brain regions, including the
frontal cortex, hippocampus, dorsal striatum, nucleus accumbens,
and the ventral tegmental area (for review see: [16]). Previous
research has largely focused on the role of glutamate in neurotoxic
damage produced by acute high doses of experimenter-adminis-
tered meth [17,18]. Under these conditions, excessive and
prolonged glutamate release in the striatum and frontal cortex is
typically observed. However, when meth delivery occurs at lower
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mission likely plays a key role in mediating rewarding and
reinforcing effects of meth [19,20]. In support of this, systemic
blockade of NMDA or mGluR5 glutamate receptors attenuated
meth self-administration [19,21,22] and blocked the reinstatement
of meth-seeking behavior [19]. In a recent study [14], we showed
that systemic allosteric modulation of mGluR5 receptors can
reverse deficits in recognition memory caused by extended meth
self-administration, suggesting that dysregulated glutamate neuro-
transmission underlies some facets of the cognitive deficits seen in
meth addiction.
In order to further investigate chronic meth-induced glutama-
tergic abnormalities, the current study analyzed changes in the
number of cell-surface (functional) mGluR2/3 and mGluR7
receptors in the medial prefrontal cortex (PFC) and the striatum
as a result of extended meth self-administration followed by a
drug-free abstinence period or daily extinction trials. We chose
these regional receptor populations based on evidence showing
that: (1) Glutamatergic input from the PFC into the striatum plays
a critical role in regulating drug-seeking [23,24,25] and certain
types of recognition memory [26], (2) mGluR2/3 and mGluR7
are highly enriched in corticostriatal projection neurons, acting as
autoreceptors in glutamatergic terminals that modulate glutamate
homeostasis during abstinence and reinstatement of drug-seeking
[25,27], and (3) extended psychostimulant induced changes in
mGluR2/3 (and possibly mGluR7) receptor sensitivity in the
corticostriatal circuitry has been postulated as a critical neuroa-
daptation linked to increased relapse vulnerability [27,28,29].
Materials and Methods
Subjects
Male Long-Evans rats (Charles River Laboratories, Wilming-
ton, MA) weighing 275–300 g at the time of delivery were
individually housed in a temperature- and humidity-controlled
vivarium on a reversed 12 h light-dark cycle. Rats received ad
libitum water throughout the study and 25 g of standard rat chow
(Harlan, Indianapolis, IN) daily until self-administration stabilized,
at which time animals were maintained ad libitum. All animal
procedures were approved by the Institutional Animal Care and
Use Committee of the Medical University of South Carolina and
were performed in accordance with the Guide for the Care and
Use of Laboratory Animals.
Catheter surgery
On the day of surgery, rats were anesthetized with ketamine/
xylazine (66 mg/kg and 1.33 mg/kg i.p.), followed by Equithesin
(0.5 ml/kg i.p.). In addition, Ketorolac (2.0 mg/kg, i.p.) was given
preoperatively as an analgesic. During anesthesia, all animals were
implanted with indwelling catheters placed into the right jugular
vein. Catheter construction and surgical procedures were
previously described [14,30]. An antibiotic solution of cefazolin
(10 mg/0.1 ml; Schein Pharmaceuticals, Florham Park, NJ) was
given along with 0.1 ml 70 U/ml heparinized saline post surgery
and during recovery. During self-administration, rats received an
infusion (0.1 ml) of 10 U/ml heparinized saline (Elkins-Sinn,
Cherry Hill, NJ) before each session. After each session, catheters
were flushed with cefazolin and 70 U/ml heparinized saline.
Catheter patency was periodically verified with methohexital
sodium (10 mg/ml dissolved in 0.9% physiological saline; Eli Lilly,
Indianapolis, IN), a short-acting barbiturate that produces a rapid
loss of muscle tone when administered intravenously.
Methamphetamine self-administration, extinction, and
abstinence procedures
Meth self-administration occurred in standard operant condi-
tioning chambers (30620620 cm, Med Associates, East Fairfield,
VT) housed inside sound-attenuating cubicles containing a fan for
airflow and masking noise. The chambers were equipped with a
house light, two retractable levers, two stimulus lights, and a tone
generator. Additionally, each chamber had a balanced metal arm
and spring leash attached to a swivel (Instech, Plymouth Meeting,
PA) with TygonH tubing extending through the leash and
connected to a 10 ml syringe mounted on an infusion pump.
Following at least 5 days of recovery from surgery, rats were
randomly assigned to either meth or yoked-saline groups and
underwent 21 days of self-administration. As shown in Figure 1A,
meth (Sigma, St. Louis, MO; 0.4 mg/ml dissolved in sterile saline)
was self-administered in 1 hr/day sessions for 7 days (short-access)
followed by 14 days of 6 hr/day (long-access). The house light
always signaled the beginning of a session and remained on
throughout the session. During the sessions, a response on the
active lever resulted in activation of the pump for a 2-sec meth
infusion (20 mg/50 ml bolus infusion) and presentation of a 5-sec
tone (78 dB, 4.5 kHz) and a white stimulus light over the active
lever, followed by a 20-sec time out. Yoked controls received a
50 ml bolus of saline when the matched subject received the
contingent meth infusion. Responses occurring during the time out
and on the inactive lever were recorded, but had no scheduled
consequences. All sessions took place during the dark cycle.
Following self-administration, rats were divided into two groups
during the 2 week withdrawal period, whereby one group
experienced daily extinction trials and the other group underwent
abstinence in the home cage (Fig. 1A). This experimental design
was based on previous studies indicating that extinction training
vs. abstinence result in distinct neural and behavioral adaptations
[31,32]. During extinction, presses on the previously active lever
were recorded but no longer produced drug or presentation of the
drug-paired cues (light+tone). In contrast, animals in the
abstinence group were transported and handled on a daily basis,
but not returned to the operant conditioning chambers.
Tissue collection and synaptosomal preparation
Fourteen days after the last self-administration session for the
abstinent group and 22 hr after the 14
th day of extinction for the
extinction group, rats were rapidly decapitated and brains quickly
removed and chilled on ice. Tissues of interest, medial PFC
(primarily prelimbic cortex), nucleus accumbens (NAc) and dorsal
striatum (dSTR), were hand-dissected from 2–3 mm thick sections
(as depicted on Figure 2A) obtained using a Precision brain slicer
(Braintree Scientific, Braintree, MA). For preparation of crude
synaptosomes, the method published by Samuvel et al. [33] was
followed, with minor modifications. Briefly, immediately after
dissection, tissues were collected and homogenized with a glass-
teflon homogenizer in ,10 volumes (w/v) of ice-cold 0.32 M
sucrose/10 mM HEPES buffer containing the following inhibi-
tors: Complete Mini protease inhibitor (Roche Diagnostics,
Indianapolis, IN) and Halt phosphatase inhibitor (Thermo Fisher
Scientific, Rockford, IL). Homogenates were first centrifuged at
800 g for 10 min at 4uC and the resulting supernatant then
centrifuged at 15,000 g for 20 min. The pellet (containing crude
synaptosomal membranes) was washed by resuspending in sucrose
buffer and protein concentrations were determined by Micro-
Bicinchoninic Acid assay according to the manufacturer’s
instructions (Thermo Fisher Scientific).
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Synaptosomes (500 mg) were treated with EZlink sulfo-NHS-SS-
biotin (1 mg/1 mg protein; Thermo Fisher Scientific) for 1 hr at
4uC in ice-cold PBS/Ca/Mg buffer [137 mM NaCl, 2.7 mM
KCl, 4.3 mM, Na2HPO4, 1.4 mM KH2PO4, 0.1 mM CaCl2,
1 mM MgCl2, pH=7.4]. Subsequently, the samples were washed
with the same buffer containing 100 mM glycine to quench
biotinylation reaction and rapidly pelleted by centrifugation. The
pellet was then resuspended by sonication in RIPA lysis buffer
[50 mM Tris HCl pH 7.6, 150 mM NaCl, 1% NP-40, 0.5%
sodium deoxycholate, 0.1% SDS] supplemented with protease
inhibitors and phosphatase inhibitors (as described above).
Following incubation for 1 hr at 4uC, insoluble debris was
removed by centrifugation at 24,000 g for 10 min and an aliquot
of precleared solubilizate (TOTAL protein) was saved. Biotiny-
lated proteins were isolated by incubating with streptavidin
agarose beads (Thermo Fisher Scientific) overnight at 4uC. After
a brief centrifugation, supernatant (unbound, NON-BIOTINY-
LATED protein fraction) was saved and beads were washed three
times with RIPA assay buffer. Bound (BIOTINYLATED) proteins
were eluted with Laemmli sample buffer (62.5 mM Tris-HCl,
pH 6.8, 20% glycerol, 2% SDS, and 100 mM DTT) for 30 min at
Figure 1. Extended access to intravenous meth results in robust self-administration and escalation of meth intake. (A) Timeline of the
experiment as described in detail in the Materials and Methods section. Animals underwent 21 days of meth self-administration (or received yoked-
saline) followed by 14 days of home cage abstinence or 14 daily extinction sessions. Tissues were collected at the end of the experiment. (B) Daily
lever responding for meth and yoked-sal animals during self-administration (left graph) and extinction (right graph). (C) Escalation of daily meth
intake during short (1 hr) and long (6 hr) self-administration sessions as detected in abstinent and extinction animals. Mean daily meth intake over
the course of the first three days vs. last three days of short- and long-access self-administration was analyzed by one-way ANOVA and expressed as
mg/kg/day of meth. (D) Total meth intake (mg/kg) in abstinent vs. extinction animals. Data shown as mean 6 S.E.M.; n=8–11 samples per group.
**p,0.01 L12–L14 vs. L1–L3.
doi:10.1371/journal.pone.0034299.g001
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LATED fractions (5 mg), and 15 ml of eluted BIOTINYLATED
fractions were separated by SDS-PAGE (4–15%), transferred to
PVDF membrane. Membranes were blocked for 1 hr in 5% milk/
Tris-buffered saline and probed overnight at 4uC with primary
antibodies diluted in 5% milk/Tris-buffered saline with 0.1%
Tween 20. The following primary antisera were used: anti-
mGluR2/3 and anti-mGluR7 (Millipore, Billerica, MA), anti-total
ERK1/2 and anti-total Akt (Cell Signalling Technology, Danvers,
MA), anti-RasD1/AGS1 [34] and anti-calnexin (Enzo Life
Sciences, Farmingdale, NY). After incubation with an appropriate
HRP-conjugated secondary antiserum (Jackson Immuno Re-
search, West Grove, PA), immunoreactive bands on the
membranes were detected by ECL+ chemiluminescence reagents
on an X-ray film (GE Healthcare, Piscataway, NJ). Subsequently,
the blots were stripped and reprobed with anti-RasD1/DexRas1
antibody to monitor biotinylation of intracellular proteins and with
anti-calnexin antibody to normalize for unequal loading and/or
transfer of proteins. The integrated band density of each protein
sample was measured using NIH Image J software version 1.32j
(http://rsb.info.nih.gov/ij/).
Statistical analysis
Meth intake (mg/kg) was calculated for the final 3 days of intake
and compared between the two meth groups using a Student’s t-
test. Immunoblotting data, represented by integrated density of
individual bands, were normalized for the density of calnexin
immunoreactivity within the same sample, analyzed by a Student’s
t-test, and expressed as the percentage of the saline-treated animals
in total or biotinylated samples. Sigma Stat (SPSS, Chicago, IL)
software was used for statistical analysis of all data. A value of
p,0.05 was considered statistically significant.
Results
Extended daily meth access results in robust self-
administration and escalation of meth intake
All animals self-administered meth, or received yoked saline
infusions, during 21 daily sessions. As shown on Figure 1B (left
panel), meth rats quickly learned to distinguish between the active
and inactive levers. This difference in responding persisted
throughout the first 7 days of short (1-hr) access, and was even
more pronounced during the 14 days of long (6-hr) access. After
completion of self-administration, rats were further divided into
two subgroups and underwent either 14 days of daily extinction
training or spent equivalent time in abstinence (Figure 1A). Self-
administration data for the abstinent subgroup was previously
reported [14], and both sub-groups displayed a similar pattern of
meth self-administration. For the extinction group, removal of
meth reinforcement produced a rapid decrease of lever pressing in
all animals (Figure 1B, right panel).
Both extinction and abstinent rats displayed a similar escalation
of daily meth intake. As demonstrated on Figure 1C, meth intake
(mg/kg/day) averaged over the last three days of 6-hr access (L12–
L14) was significantly higher than average daily intake measured
over the first three days of 6-hr access (L1–L3) in both abstinent
(t(13)=23.875, p,0.001) and extinguished subgroups of rats
(t(13)=25.926, p,0.001). This escalation was specific for the
extended 6-hr access period and did not occur during the initial 7
days of limited 1-hr access (Figure 1C). In addition, no differences
were found between abstinent and extinguished animals in their
total cumulative meth intake across the self-administration period
(t(17)=21.764, p=0.096; Figure 1D).
Analysis of surface vs. intracellular distribution of
mGluR2/3 and mGluR7 receptors in synaptosomes
isolated from rat prefrontal cortex and striatum
The majority of previous studies on drug-induced regulation of
mGluR receptors have been limited to measurement of total tissue
content. The current study employed surface biotinylation
techniques in order to measure not only the total number of
receptors, but also a pool of surface (presumably active) mGluR2/
3 and mGluR7 receptors present in synaptosomal fractions
prepared from meth and saline control rats. Figure 2A shows
the rat brain atlas coordinates used as guidelines for tissue
dissection for preparations of crude synaptosomal fraction. A
representative immunoblot analysis of biotinylated synaptosomes
isolated from the dorsal striatum (dSTR) is depicted in Figure 2B.
Figure 2. Analysis of mGluR2/3 and mGluR7 surface vs. intracellular distribution in rat brain synaptosomes. (A) Rat brain atlas
coordinates (adapted from [77]) used for tissue dissection and synaptosome preparation. (B) Representative immunoblots showing surface vs.
intracellular distribution of mGluR2/3 and mGluR7 receptors (as well as marker proteins: calnexin, ERK1/2 and RasD1/AGS1) in synaptosomal fraction
prepared from the dSTR. P2* - synaptosomal fraction resolved under strongly reducing conditions (100 mM DTT); T – total synaptosomal fraction
after biotinylation resolved under weakly reducing conditions (.10 mM DTT); NB – non-biotinylated (intracellular) proteins; B – biotinylated (surface)
proteins isolated by precipitation with streptavidin-agarose beads.
doi:10.1371/journal.pone.0034299.g002
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proteins in the dSTR, which corresponds with the fact that both
receptors heavily populate glutamatergic afferents into the
striatum [35]. We found that the majority of mGluR2/3s or
mGluR7s in this brain region were found on the cell surface (B,
biotinylated fraction), with only a limited amount present in the
intracellular compartment (NB, non-biotinylated fraction). Under
the low reducing conditions used in this study (,10 mM DTT),
mGluR2/3 and mGluR7 were detected almost exclusively in a
dimer form (200–220 kDa), a pattern described previously in both
rat and human brain [36,37]. However, under strongly reducing
conditions (100 mM DTT, P2* fraction), both mGluR2/3 and
mGluR7 dimers were dissolved and migrated as monomers
(,100–110 kDa; Figure 2B). Since dimerization/oligomerization
of G-protein coupled receptors is an essential step in the
generation of ‘‘mature’’ functional complexes [38,39], only the
dimeric form of mGluR2/3 and mGluR7 receptors was analyzed
in the present study.
Control protein calnexin was found to be present in all fractions,
although to a lesser extent in the biotinylated, surface fraction. This
fact could be explained either by the ‘normal’ occurrence of
calnexin in the plasma membrane [40,41], or by the presence of
broken membrane fragments or leaky synaptosomes in a relatively
crude synaptosomal preparation as used in this study (see also [42]).
However, prototypical intracellular proteins like ERK1/2 or Ras-
like protein RasD1/AGS1 [43] showed only minimal or no
presence in the surface (biotinylated) fraction, suggesting that non-
specificbiotinylationofintracellularproteinswaslimited(Figure2B).
Meth followed by abstinence results in decreased surface
and/or total expression of mGluR2/3 in the medial
prefrontal cortex and striatum
As demonstrated in Figure 3 (left panels), chronic meth self-
administration followed by abstinence resulted in a decreased
number of mGluR2/3 receptors present on the surface of
synaptosomes (i.e., biotinylated fraction or ‘B’) isolated from the
medial prefrontal cortex (PFC; t(17)=3.69, p,0.01, Figure 3A),
nucleus accumbens (NAc; t(17)=2.37, p,0.05, Figure 3B), and
dSTR (t(20)=4.35, p,0.01, Figure 3C), when compared to
mGluR2/3 surface levels in control animals. In addition, total
mGluR2/3 receptor levels were also decreased in the NAc
(t(17)=3.05, p,0.01, Figure 3B) and dSTR (t(20)=3.65, p,0.01,
Figure 3C) of meth animals when compared to their saline
counterparts. As for mGluR7 (Figure 3, right panels), meth-
induced changes were limited to lower surface levels in the PFC
(t(17)=2.80, p,0.05, Figure 3A, right panel).
Meth followed by daily extinction results only in a
decreased surface expression of mGluR2/3 in the medial
prefrontal cortex
In contrast to the multiregional changes in mGluRs seen after
abstinence from meth self-administration, chronic meth self-
administration followed by daily extinction only resulted in a
decreased number of surface mGluR2/3 receptors in synapto-
somes isolated from the medial PFC (t(13)=2.37, p,0.05,
Figure 4A, left panel). Changes in total or surface levels of
mGluR2/3 (Figure 4, left panels) or mGluR7 (Figure 4, right
panels) were not detected in any other analyzed brain regions.
Discussion
The present study demonstrates that extended access to meth
self-administration results in escalated meth intake and persistent
alterations in total and/or surface levels of mGluR2/3 and
mGluR7 receptors within the corticostriatal circuitry. Importantly,
meth-induced changes in mGluR levels are clearly dependent on
the conditions of post meth withdrawal. Specifically, daily
extinction trials reversed the downregulation of striatal
mGluR2/3 receptors found in abstinent rats (who had no
extinction experience). In contrast, escalated meth self-adminis-
tration decreased surface levels of mGluR2/3 receptors in the
medial PFC, regardless of post meth experience. These results
suggest that extinction learning can selectively restore specific
populations of down regulated mGluRs after prolonged exposure
to meth. The potential significance of the present findings for the
persistence (or the recovery) of meth-induced motivational and
cognitive deficits is discussed below.
A large body of evidence from both preclinical and clinical
studies suggests that persistent drug seeking and increased risk of
relapse are driven by drug-induced neuroadaptations within
specific brain circuits of motivation. In animal models, factors
contributing to drug seeking have been traditionally studied
following extinction, rather than abstinence [44], in order to
reduce operant responding prior to reinstatement of drug seeking.
While the use of extinction procedures is highly useful for these
models, explicit extinction training has been used only infrequently
in the treatment of drug addiction [45,46] and relapse in humans
typically occurs after an untreated drug-free period (i.e.,
abstinence). Extinction training (in contrast to abstinence) involves
new learning about the drug-taking environment and as result,
drug-seeking after extinction engages brain circuitry differently
than that of abstinence (see [47] for review). For example,
inactivation of the projections from the dorsomedial PFC
(prelimbic cortex) to the NAc (core subregion) blocks the
reinstatement of methamphetamine or cocaine seeking in
extinguished animals [48,49,50]. However, inactivation of dSTR,
but not the dorsomedial PFC or NAc inhibits drug seeking in
animals following abstinence [32,51], indicating that extinction
training recruits PFC-to-NAc projections in the regulation of drug-
seeking. In addition, a dorso-ventral functional divide within the
medial PFC has been shown to emerge during extinction training
after cocaine self-administration, whereby the dorsomedial PFC
(prelimbic cortex) drives cocaine seeking, while the ventromedial
PFC (infralimbic cortex) suppresses it [52]. Importantly, such a
division does not exist for animals with a history of meth self-
administration, in that inactivation of either the dorsal or ventral
PFC attenuates meth seeking [50].
Besides engaging different neurocircuitry, extinction training
has also been shown to produce glutamatergic neuroadaptations
that differ from those found in abstinent animals [31,53,54,55].
Thus, the current study focused on analysis of presynaptic
Figure 3. Extended access to intravenous meth followed by abstinence results in decreased surface and/or total expression of
mGluR2/3 in the PFC and striatal subregions and decreased surface expression of mGluR7 in the PFC. Top panels: Representative
immunoblots show levels of mGluR2/3 and mGluR7 protein in total (T) and surface (B, biotinylated) synaptosomal fractions isolated from the PFC (A),
NAc (B), and dSTR (C), following meth self-administration and 14 days of abstinence. Lower panels: Quantitative analyses of immunoblots revealed
significant decreases in total mGluR2/3 levels (B, C), surface mGluR2/3 levels (A, B, C) and surface mGluR7 levels (A) in meth vs. saline rats. Integrated
density of each band was analyzed by one-way ANOVA and expressed as the percentage of the saline-treated animals. Data shown as mean 6 S.E.M.;
n=11 samples per group. *p,0.05, **p,0.01 vs. Sal.
doi:10.1371/journal.pone.0034299.g003
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after extinction (dorsomedial PFC and NAc), as well as in the
dSTR, which is necessary for drug-seeking after abstinence. In
abstinent animals, mGluR2/3 receptors (both total and surface
populations) were found to be downregulated in all three regions
studied, with mGluR7 being significantly decreased only in the
PFC. Interestingly, daily extinction training ‘normalized’
mGluR2/3 levels in the striatum and mGluR7 levels in the
PFC. In agreement with these results, extinction may reverse or
ameliorate glutamatergic neuroadaptations within the corticos-
triatal circuitry produced by chronic drug exposure and
withdrawal (abstinence), and as a result reduce drug-seeking
[56,57]. mGluR2/3 and mGluR7 are the most abundant
presynaptic glutamate autoreceptors found on corticostriatal
glutamatergic terminals [58,59] and activation of either
mGluR2/3 or mGluR7 inhibits drug-seeking through inhibition
of corticostriatal glutamate transmission during reinstatement
[60,61]. Therefore, a decrease in mGluR2/3 autoreceptor
function (such as decreased surface expression of mGluR2/3
receptors described in the current study) may contribute to
increased releasability of glutamate in the striatum and enhanced
reinstatement of drug seeking [27,62]. Indeed, prolonged meth
self-administration followed by abstinence resulted in a robust
reinstatement [63] and sensitized response of NAc glutamate to a
meth-priming injection [20]. Interestingly, the ability of mod-
afinil, a putative mGluR2/3 agonist [64], to block reinstatement
of meth seeking is also attenuated in abstinent animals when
compared to their extinguished counterparts [63]. These findings
further support the possibility that corticostriatal mGluR2/3
receptor function is decreased after abstinence from chronic
meth, but can be recovered with extinction training.
Different brain region-specific cellular mechanisms could be
implicated in regulation of mGluR2/3 and mGluR7 receptors
reported in the present study. Since mGluR2/3 and mGluR7 in
the striatum (NAc and dSTR) are almost exclusively located
within axon terminals [58,59], simultaneous downregulation and
recovery of total and surface receptor levels could be a
consequence of both local (striatal) and extra-striatal regulatory
mechanisms. For example, decreased availability of striatal
mGluR2/3 receptors in abstinent meth rats could arise from
disrupted receptor membrane trafficking at the striatal synapse,
as well as from decreased protein synthesis and anterograde
delivery of mGluR2/3s from striatal input regions. The relative
contribution of each mechanism will need to be addressed in
future studies. On the other hand, surface (but not total) levels of
mGluR2/3 and mGluR7 receptors were altered in the medial
PFC, indicating specific changes in mechanisms regulating
receptor surface trafficking. Extinction-dependent regulation of
mGluR5 receptor trafficking has been recently reported [53];
however, the current data are the first to suggest chronic
psychostimulant-induced changes in mGluR2/3 and mGluR7
receptor trafficking in glutamatergic presynaptic terminals. It
should be noted that in the present study and other previous
studies using crude synaptosomal preparations, a general
assumption is that the analysis reflects changes in surface
trafficking within nerve terminals. However, this type of
preparation is not completely devoid of glial membrane
fragments [65]. Since functional mGluR2/3 receptors have been
described in astrocytes [66], it cannot be ruled out that meth self-
administration and post-meth experience alters mGluR2/3 levels
in non-neuronal membranes.
Reduced levels of mGluR2/3 and mGluR7 receptors
observed in the striatum (and PFC) after high doses of meth
may have potentially been caused by neuronal damage or glial
activation as a result of neurotoxicity [67]. However, this is
unlikely as: a) meth-induced decreases in presynaptic mGluRs
were reversed by extinction training, and b) we have previously
shown that this particular extended access meth self-adminis-
tration regimen does not produce lasting neurotoxicity in the
forebrain as markers for dopamine terminals, astrocytes, and
microglia were not altered at 7–14 days after meth self-
administration [13,68].
Previous findings from our laboratory and others have
demonstrated that rats with extended access meth self-
administration display both enhanced drug seeking [12,13], as
well as deficits in cognitive and memory domains [12,14,68].
These deficits persist at least up to 14 days after the last meth
self-administration session [12,14,68], which correlates with our
findings of dysregulated mGluR levels at this time point (current
study). Disrupted mGluR2/3 and/or mGluR7 receptor function
in the forebrain has also been implicated in deficits in cognitive
processing often diagnosed in patients with schizophrenia [69],
with findings from several preclinical models of schizophrenia as
well as from postmortem studies showing decreased levels of
mGluR2/3 receptors, predominately in the PFC [70,71]. Since
chronic meth exposure has been used to model some
schizophrenia symptoms in experimental animals [72,73], it is
possible that meth–induced memory and cognitive deficits could
also be attributed to altered mGluR2/3 function. In particular,
since the deficits have been previously detected in animals
regardless of extinction training [12,14], disrupted surface
trafficking of mGluR2/3 in the PFC could represent a critical
neurobiological meth-induced deficit, independent of post-meth
experience. The exact neurobiological mechanisms by which
meth self-administration alters homeostasis of mGluR2/3
receptor trafficking remains unknown and will be pursued in
future experiments.
In conclusion, the current study presents novel findings on
potential substrates of motivational and cognitive deficits found in
animals after extended access to meth self-administration.
Specifically, meth produces a prolonged downregulation of
mGluR2/3 and mGluR7 surface expression within the corticos-
triatal circuitry of abstinent animals, an effect that can be reversed
(at least in the striatal glutamatergic terminals) by daily extinction
during withdrawal. While future studies will need to directly assess
the behavioral significance of altered corticostriatal mGluR2/3
and mGluR7 receptors, these findings are of particular significance
as recent evidence suggests that agents which positively modulate
function of mGluR2/3 receptors (e.g., modafinil, [64]) also inhibit
meth seeking [63,74] and may possess therapeutic potential both
for the prevention of relapse and improving cognitive deficits in
meth-dependent individuals [75,76].
Figure 4. Extended access to intravenous meth followed by extinction results in decreased surface expression of mGluR2/3 in the
PFC. Top panels: Representative immunoblots show levels of mGluR2/3 and mGluR7 protein in total (T) and surface (B, biotinylated) synaptosomal
fractions isolated from the PFC (A), NAc (B), and dSTR (C) following meth self-administration and 14 days of extinction. Lower panels: Quantitative
analyses of immunoblots revealed significant decreases in surface mGluR2/3 levels in the PFC (A). Integrated density of each band was analyzed by
one-way ANOVA and expressed as the percentage of the saline-treated animals. Data shown as mean 6 S.E.M.; n=8 samples per group. *p,0.05 vs.
Sal.
doi:10.1371/journal.pone.0034299.g004
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